Profile: Jennerex, Inc. is specialized in offering biotherapeutics. We focus on the discovery and the development of cancer therapeutics that have been engineered to target, attack and eradicate cancer without harming the surrounding cells. Our JX-594 product is based on the vaccinia virus strain which is unique to treat cancers, and it is genetically modified by deleting its thymidine kinase gene to enhance cancer selectivity. We also design and develop drug candidates for the treatment of cancer that have different but complementary spectrum of anti-cancer activity than the products currently in clinical development.